Genetic Technologies Ltd has released a press release.
geneType Granted Approval for 3 New Diseases in Australia
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Annual Results Momentum Building on our Commercial Plans
- 2023 Annual Report and Appendix 4E
- Updated Investor Presentation - August 2023
- Appendix 4C and Quarterly Activities Report - June 2023
- Publication Validates geneType for Melanoma Risk Assessment
Later from Genetic Technologies
- MRFF Grant Names GTG as Sole Industry Partner
- GTG & Gold Coast Hospital Announce Precision Medicine Pilot
- Appendix 4C and Quarterly Activities Report - September 2023
- Consolidation/Split - GTG
- 2023 AGM Presentation
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies